Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).
about
Human complement receptor 2 (CR2/CD21) as a receptor for DNA: implications for its roles in the immune response and the pathogenesis of systemic lupus erythematosus (SLE)Epstein Barr virus/complement C3d receptor is an interferon alpha receptorSelectinsT lymphocyte expression of complement receptor 2 (CR2/CD21): a role in adhesive cell-cell interactions and dysregulation in a patient with systemic lupus erythematosus (SLE)The C3b/C4b receptor is recognized by the Knops, McCoy, Swain-langley, and York blood group antiseraComplement receptor 1 polymorphisms associated with resistance to severe malaria in KenyaComplement in Lupus Nephritis: New PerspectivesThe complotype: dictating risk for inflammation and infectionNeutrophil-Mediated Phagocytosis of Staphylococcus aureusComplement receptor 1 is a sialic acid-independent erythrocyte receptor of Plasmodium falciparumTag SNPs in complement receptor-1 contribute to the susceptibility to non-small cell lung cancerComplement consumption in children with Plasmodium falciparum malariaUse of heteropolymeric monoclonal antibodies to attach antigens to the C3b receptor of human erythrocytes: a potential therapeutic treatmentMapping of the C3d ligand binding site on complement receptor 2 (CR2/CD21) using nuclear magnetic resonance and chemical shift analysis.Complementary recognition of alternative pathway activators by decay-accelerating factor and factor HBiophysical investigations of complement receptor 2 (CD21 and CR2)-ligand interactions reveal amino acid contacts unique to each receptor-ligand pairThe genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE.Structure-function analysis of decay-accelerating factor: identification of residues important for binding of the Escherichia coli Dr adhesin and complement regulationMajor histocompatibility complex class III genes and susceptibility to immunoglobulin A deficiency and common variable immunodeficiency.The complement system: history, pathways, cascade and inhibitors.Human genetic polymorphisms in the Knops blood group are not associated with a protective advantage against Plasmodium falciparum malaria in Southern Ghana.Complement activation by whole endotoxin is blocked by a monoclonal antibody to factor BIg beta tyrosine residues contribute to the control of B cell receptor signaling by regulating receptor internalization.Complement and systemic lupus erythematosus.A new mouse anti-mouse complement receptor type 2 and 1 (CR2/CR1) monoclonal antibody as a tool to study receptor involvement in chronic models of immune responses and disease.Anaemia & expression levels of CD35, CD55 & CD59 on red blood cells in Plasmodium falciparum malaria patients from India.A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria.Bordetella pertussis binds the human complement regulator C4BP: role of filamentous hemagglutinin.Role of complement receptor 1 (CR1; CD35) on epithelial cells: A model for understanding complement-mediated damage in the kidney.Quantitative Modeling of the Alternative Pathway of the Complement SystemHigh Incidence of Malaria Along the Sino-Burmese Border Is Associated With Polymorphisms of CR1, IL-1A, IL-4R, IL-4, NOS, and TNF, But Not With G6PD Deficiency.The rickettsial OmpB β-peptide of Rickettsia conorii is sufficient to facilitate factor H-mediated serum resistanceDevelopment of complement therapeutics for inhibition of immune-mediated red cell destructionComplement-dependent transport of antigen into B cell follicles.Genomic organization of the selectin family of leukocyte adhesion molecules on human and mouse chromosome 1Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2.Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcgamma receptor III.Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA.Determination of the role for CD21 during Epstein-Barr virus infection of B-lymphoblastoid cells.The role of complement component C3b and its receptors in sperm-oocyte interaction.
P2860
Q24296010-B03E9D15-11D1-482F-BE94-24E1B04737C6Q24561504-853FA3A7-1E2C-47D9-B1F2-0B2633D8780AQ24602099-5275ACA3-6454-4F50-AEE2-780F4D545153Q24672100-4E99F534-B84C-4D36-9CC6-6F88E287F482Q24675861-1676CD93-78CB-4F12-9FCC-B3F664230E0BQ24815618-9482840D-E35F-4CE1-85E2-B549B6EC4040Q26740491-611EB2BB-7DD6-43B7-A022-9EEE3F7005A8Q26862665-D4D4C343-A002-40EE-8E85-6AAB0EF370D0Q27025128-567609CF-9639-493F-98C1-2F857003D3C2Q27314003-45032F58-E3A3-4BC4-8DCC-4C1689AB7FE6Q28384476-EC8CDAF1-0447-4953-919B-F36D985EF90FQ30440213-0D337A28-82FD-44DA-844A-86631936772FQ30445571-8129D1A1-0540-4822-9F47-E52057A9E547Q33402381-A63740D1-037A-4422-9A61-2D27FEE9F7D7Q33749851-356D49B6-D705-4DEA-82BC-764E6E0D3E0EQ34094547-DDB89E0B-F063-434A-AD82-537F35D964FAQ34123651-120442E9-186A-44B6-984A-73F374BF92AAQ34127130-DDE6DBBE-E8D8-4D05-852D-4E14AC507940Q34220904-E10586F4-32E3-4E35-8294-D2194E661641Q34412336-346F0415-4211-4967-ACF1-8F8F568AC5C0Q34481349-E1074495-F849-4432-865D-F7EFFE1B3A88Q34541798-A434504D-A927-426F-86C5-6F0473613BC8Q34544332-4EE49B4A-05E4-4E27-AE00-7493F112EF68Q34731255-12B88F97-9DC4-4172-A366-D275A9908957Q35002158-0B8B83A8-A5BF-4FF0-88D0-7BFFEACAD4BCQ35104294-56F20089-AB1C-4A6B-9076-80E8FA04410DQ35122417-CB818135-3B46-4BF8-AE22-2B1DDFBEC78EQ35554587-5C2ABF35-7F98-42B9-84FD-968F64DCA054Q35741851-BF0CAB01-579E-40F6-9986-6765CBC771F2Q35975481-F1535CF5-87B7-476B-843E-E6BB09D9BDDAQ36195402-D8DAA262-E88C-4BEC-AA12-276256D3143FQ36211176-601C5BEA-4DB7-4D30-801C-E1427232128EQ36222203-84F35F1B-8F2B-44B5-A918-816D6C051D9EQ36337689-0E4D646B-6535-4FEF-BC8D-DCF912DE6F76Q36352069-E4B68FA9-46C7-4AFC-A0C7-BD3357303D92Q36357106-B6E4BA13-C94C-4306-B43B-2652DF671D9EQ36368392-418DE90E-027A-48C1-A0DA-82C16C10AE65Q36475603-32AC0C1D-B0A8-4646-A3CF-F3B9038625B7Q36623632-D24C5F54-3D7D-466A-8A4B-353F2B49C331Q36630669-4AC53A2A-968B-4AA0-B003-2116941F8099
P2860
Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).
description
1989 nî lūn-bûn
@nan
1989 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).
@ast
Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).
@en
Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).
@nl
type
label
Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).
@ast
Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).
@en
Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).
@nl
prefLabel
Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).
@ast
Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).
@en
Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).
@nl
P1476
Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).
@en
P2093
P304
P577
1989-01-01T00:00:00Z